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Introduction
Extracorporeal membrane oxygenation (ECMO) is a 
modied form of cardiopulmonary bypass (CPB) used 
to provide adequate organ oxygenation in patients 
with cardiac and/or respiratory failure. The scope of 
this article is to give general practitioners and special-
ists not involved in ECMO management a brief over-
view of indications, surgical implantation and patient/
parental management for children treated with ECMO. 
Indications and types of ECMO 
ECMO is a partial or complete support of ventilation 
and oxygenation, as well as uni- or biventricular sup-
port of myocardial function. It operates by removing 
blood from the patient’s venous circulation, pumping 
it through an oxygenator to remove carbon dioxide 
and oxygenate haemoglobin, and subsequently re-
turning it to either the arterial (VA-ECMO) or venous 
(VV-ECMO) circulation. In VA-ECMO the articial lung 
is in parallel with the native lungs. This allows su-
cient oxygenation, as well as cardiac output. The abil-
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Summary
Extracorporeal membrane oxygenation (ECMO) is a general term that de-
scribes the short- or long-term support of the heart and/or lungs in neonates, 
children and adults. It offers a treatment option for severe cardiac and/or 
respiratory failure from neonate to adult. Used as venoarterial extracorpor-
eal membrane oxygenation (VA-ECMO), it remains the most commonly 
used modality for short- to mid-term mechanical support of the failing circu-
lation in children. The aim of this article is to review the clinical indications, 
different circuits, technical options, patient management, and potential risks 
and benefits of this therapy for children. As ECMO therapy is an overwhelm-
ing event for the whole family we also highlight the role of psychosocial 
counselling and support for the parents.
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ity to provide support for both lung and heart function 
is the major dierence of VA-ECMO from VV-ECMO. In 
VV-ECMO the articial lung is situated in series with 
the native lungs; cardiac function must be adequate to 
maintain pulmonary and systemic perfusion. 
Pulmonary or/and myocardial failure are the main in-
dications for the clinical application of ECMO (table 1). 
Despite growing experience, some clinical features re-
main contraindications for ECMO therapy (table 2).
Although patient retrieval on ECMO is feasible, pa-
tients with a high probability of requiring ECMO ther-
apy are ideally transferredin good time to ECMO cen-
tres with signicant expertise in paediatrics [2, 3]. 
Patient  are preferably referred before ongoing deterio-
ration of the underlying medical condition occurs, pa-
tient transport is precluded by their condition or sec-
ondary additional organ damage is observed [4].
The ECMO circuit
We use a Thoratec Centrimag® or PediVas® (Levitronix, 
 Zurich, Switzerland) console with a back-up unit, a 
heater unit and a Sechrist Air-Oxygen-Mixer (Sechrist 
Industries,  Anaheim, USA) (g. 1). For neonates and in-
fants weighing up to 15 kg the whole circuit contains 
approximately 250 ml priming solution with ow 
ranges up to 1.7 l/min; for children above 15 kg the vol-
ume of priming solution is about 750 ml and ow rates 
up to 7.0 l/min can be achieved. 
Implantation techniques  
and cannulation sites
Weight limits for dierent cannulation sites and vari-
ous cannulation algorithms have been published [5, 6]. 
Cannulation for neonates, infants and small children 
focuses on either neck vessels or large central vessels 
via median sternotomy. Cannulation of the femoral 
vessels in small children is not possible because the 
small size of the vessels does not allow implantation of 
cannulae large enough to achieve full ECMO ow. 
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Neck cannulation has the advantage of allowing an ex-
peditious procedure in an emergency situation, even 
during  mechanical cardiopulmonary resuscitation 
without interrupting chest compression. A transverse 
skin incision is made over the lower third of the ster-
nocleidomastoid on the right side. The internal jugular 
vein, the common carotid  artery and the vagal nerve 
are identied. Oval purse-string sutures are placed in 
vein (VV-ECMO) and artery (VA-ECMO). Selected cannu-
las, according to the weight of the patient and desired 
achievable ow rate, are inserted through a vertical in-
cision within the purse-string suture, tightened over 
tourniquets and connected to the ECMO circuit. 
A heparin bolus of 50–100 IU/kg is administered inde-
pendently of the cannulation site prior to inserting the 
cannulas. Subsequently, continuous heparin infusion 
is titrated using a goal activated clotting time  in the 
range of 160–180 seconds. The platelet count is main-
tained at or above 100 000/mm3. One perioperative in-
jection of prophylactic antibiotic (cefazolin) is admin-
istered at each ECMO implantation. 
The role of echocardiography for paediat-
ric patients supported with ECMO
Echocardiography should be used preoperatively for 
patient selection, perioperatively for cannula place-
ment and lling of the le¥ ventricle and postopera-
tively for surveillance,  optimisation, troubleshooting 
and evaluation of myocardial recovery. Whenever pos-
sible, echocardiography is performed before ECMO 
cannulation to conrm signicant systolic ventricular 
dysfunction as indication for implantation and to 
Table 1: Extracorporeal membrane oxygenation indications. 
Heart failure Failure to wean from CPB
Myocarditis
Cardiomyopathy (bridge to recovery, 
transplant or long term MCS)
Refractory sepsis with profound cardiac 
depression*
Refractory cardiac arrhythmias 
Coronary ischaemia (if surgically amen-
dable/treatable)
Pulmonary failure Bridge to transplantation
Neonatal respiratory distress syndrome
Adult respiratory distress syndrome† 
Persistent pulmonary hypertension of the 
newborn / persistent fetal circulation
Meconium aspiration syndrome
Pneumonia (viral/bacterial/aspiration)
Air leak syndrome
Cardiac arrest  
from any cause‡ 
Bridge to decision, underlying treatable 
disease
Transplantation Pre-transplantation as bridge to Tx
Primary graft dysfunction after heart or 
lung Tx
Elective periproce-
dural support 
During lung transplantation or tracheal 
surgery
Congenital dia-
phragmatic hernia 
In special circumstances; centre specific
(CPB = cardiopulmonary bypass; MCS = mechanical circulatory 
support; Tx = transplantation) 
* In patients with impaired cardiac output who cannot sufficiently in-
crease cardiac output in sepsis; the team has to be aware that further 
invasive treatment (surgery, e.g., thoracotomy or laparotomy) on ECMO 
therapy is associated with higher complication rates (bleeding) than 
normal [8].
† In children and adolescents. 
 ‡ Depending on clinical situation; not suitable if outcome is 
unpromising.
Table 2: Contraindications for extracorporeal membrane 
oxygenation therapy.
End-stage disease
Untreatable underlying disease and congenital 
 malformations
Significant neurological impairment, genetic abnormalities 
(e.g., trisomy 13 and 18)
Severe, irreversible organ dysfunction
Extreme prematurity (gestational age <35 weeks)
Severe coagulopathy or contraindication for anticoagulation
Figure 1: The ECMO circuit used at the Children’s hospital 
Zurich including a Thoratec Centrimag® pump, a heater unit, 
a Sechrist Air-Oxygen-Mixer and a Polymethylpentene hol-
low-fibre oxygenator.
Published under the copyright license “Attribution – Non-Commercial – NoDerivatives 4.0”. No commercial reuse without permission. See: http://emh.ch/en/services/permissions.html
REVIEW ARTICLE 59
CARDIOVASCULAR MEDICINE – KARDIOVASKULÄRE MEDIZIN – MÉDECINE CARDIOVASCULAIRE 2017;20(3):57–61
eliminate residual haemodynamic lesions that could 
be resolved other than by ECMO installation. Further-
more, echocardiography is used to rule out cardiac 
anomalies, and assure that there are competent valves 
and normal systemic veins.
During ECMO implantation, echocardiography can 
guide the insertion and correct placement of the can-
nulas and document the volume state of the le¥ ventri-
cle. If VV-ECMO with a dual-lumen cannula (AVALON®, 
Avalon Laboratories, LLC, California, USA) is inserted 
via a single site (internal jugular vein), we use echocar-
diographic or x-ray guidance in the cardiac catheter 
laboratory to ensure adequate orientation of the ports 
of the cannula (g. 2). Their proper position must be 
conrmed with echocardiography, especially the loca-
tion of the outow lumen, which must be positioned in 
the centre of the right atrium with ow directed to-
wards the tricuspid valve. The hepatic veins and the 
distal inferior vena cava should not be congested. 
The rst echocardiogram a¥er ECMO implantation on 
the intensive care unit (ICU) veries again the localisa-
tion of the cannulas. Complications arising from the 
cannulas include displacement, malposition or ob-
struction [7]. 
Repeated echcardiographic monitoring in a child on 
ECMO is mandatory and includes the course of le¥ ven-
tricular size and contractility, aortic valve opening and 
mitral valve regurgitation. If the aortic valve is not 
opening and there is no shunt, the le¥ ventricle of a pa-
tient on VA-ECMO will not unload. If the le¥ ventricule 
than dilates, recovery is not possible. In this case an ad-
ditional cannula (vent) has to be implanted in the le¥ 
ventricle or atrium, or an atrioseptostomy is needed, 
to ensure sucient unloading. 
Complications must be anticipated and specically 
screened for, and are o¥en associated with either the 
cannula itself or the anticoagulation regimen. Anti-
coagulation can lead to bleeding, resulting in pericar-
dial eusion and subsequently tamponade, or forma-
tion of a thrombus either in the heart, the vessels or 
the cannulas. 
Patient management on the ICU
In order to achieve the desired goal of optimal pulmo-
nary and/or myocardial support and with optimal bal-
ance of blood ow, oxygen delivery and oxygen con-
sumption, the following aims are crucial:
1. Provision of adequate oxygenation and CO2 removal 
in pulmonary dysfunction.
2. Provision of adequate blood ow to match meta-
bolic needs in patients with insucient cardiac out-
put.
3. Prevention of complications from other therapies 
as well as from the ECMO therapy itself.
Numerous considerations need to be addressed when 
caring for ECMO patients, as they will inuence course 
and outcome (e.g., anticoagulation, nutrition, infection, 
renal function, psychosocial family support and ethical 
considerations). Nevertheless, it is important at the be-
ginning of an ECMO run to have a clear view of the 
likely length of support required and the ultimate des-
tination. This may be complete recovery, bridge to deci-
sion, bridge to transplant or bridge to longstanding car-
diac support such as a ventricular assist device. 
ECMO support might only be necessary for as little as 3 
to 6 days (e.g., myocardial recovery a¥er intraoperative 
stun, persistent pulmonary hypertension of the new-
born or vasoplegic shock in sepsis) [8], up to 10 to 14 
days, or even signicantly longer (e.g., adult respiratory 
distress syndrome, pneumonia, meconium aspiration 
syndrome, myocarditis) [9–11]. Time on ECMO support 
should be used wisely if uncertainties about the under-
lying disease process remain. If echocardiography 
leaves questions unanswered, a cardiac catheter study 
can usually safely be undertaken and should meticu-
lously investigate the patient’s haemodynamic state or 
search for residual lesions, as this will probably have di-
rect implications for the ongoing ECMO support and for 
immediate decisions [12]. The patient on ECMO needs 
precise and fastidious anticoagulation management, 
because bleeding, haemolysis and thrombosis should 
be prevented as far as possible, as they are primarily re-
sponsible for neurological sequelae and dismal out-
come [13]. Near-infrared spectroscopy (NIRS) has 
Figure 2: Implanted VV-ECMO using a single-lumen cannula 
(AVALON) showing proper placement in the catheter labora-
tory.
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evolved as a reliable tool to guide therapy in order to 
improve neurological outcomes a¥er ECMO therapy 
[14]. NIRS provides indirect monitoring of venous drain-
age and arterial perfusion. In contrast to echocardiog-
raphy, NIRS allows permanent monitoring [15].
Nursing care
The monitoring and care of children with ECMO ther-
apy is a special nursing challenge and requires close 
multidisciplinary cooperation. The ICU nurses are spe-
cically trained for ECMO therapy and are therefore 
able to respond to acute changes at any given time [17, 
18]. During ECMO support children are rest-ventilated, 
sometimes with an open sternum due to a delayed 
sternal closure a¥er central cannulation. Any manipu-
lation of the positioning of the patient (e.g., wound 
care, pressure ulcer care or changing endotracheal 
tube straps) may change the position of the ECMO can-
nulas, which can negatively aect the ECMO ow and 
may even lead to failure of the ECMO circuit. Therefore, 
ECMO specialist nurses need to be extremely vigilant 
and respond to these changes. The risks of infections, 
cerebral haemorrhage and renal failure (e.g., due to de-
creased renal perfusion during non-pulsatile ECMO 
ow) are increased and will rise with increasing dura-
tion of ECMO therapy. Therefore, careful clinical moni-
toring of the patient, as well as meticulous antiseptic 
precautions at the cannulation site, are vitally neces-
sary. ECMO patients are exposed to an increased risk of 
bleeding [19]. Because of bleeding and blood trauma, 
some patients will need to have blood products several 
times daily [20]. The nurses continuously monitor 
every organ system and have to be able to indepen-
dently and competently respond to emergencies at any 
time. Ideally, there are always two nurses responsible 
for one child on ECMO, sharing the complex supervi-
sion and care of the patient.
Our patients (children and adolescents) are always part 
of their personal environment – their parents and 
other family members. Initially, the parents and fami-
lies of the children experience a tremendous shock. Es-
pecially with neonalal patients, building a relationship 
with their newborn child is a big challenge for parents. 
They are not able to hold and care for their child [21], 
and the uncertainty of the outcome aggravates the sit-
uation. It is part of the nursing care to support relatives 
during this time, as well as during grieving if the out-
come is not favourable. The regular presence of parents 
and family at the bedside is very important for a criti-
cally ill child. To support and to build a solid relation-
ship, as well individual contact with their child, it is 
important to integrate the parents in nursing inter-
ventions such as oral care, skin care, changing nappies 
or massages. A soothing touch, the parents’ and sib-
lings’ voices, personal toys, music and rituals can be 
very helpful for the ill child, and also for the family. 
Parents and family members o¥en need detailed infor-
mation while their child is on ECMO support and, de-
pending on their personalities, are also o¥en them-
selves in need of encouragement and personal support, 
a task the ECMO specialist nurse should provide. 
Nurses are in a particular situation to care for these 
highly complex patients, and to support the whole 
family (table 3).
Table 3: Responsibilities of the nursing team caring for 
children on ECMO. 
Responsibilities of the ECMO nurse
Psychological family support 
Visual inspection of the ECMO circuit
Regulation of ECMO flow, sweep gas and oxygenation
Anticoagulation management
Management of the heparin infusion and administration 
of blood products
Haemofiltration
Emergency measures and troubleshooting of the ECMO 
circuit until perfusionists take over
Responsibilities of the bedside nurse
Basic care
Intravenous fluid administration and medical therapy
Feeding and administration of parenteral nutrition
Vital signs monitoring
Monitoring of fluid intake and output
Nursing documentation
Nursing assessment, nursing process, nursing diagnoses
Conclusion
Over the last decades ECMO has become the most fre-
quently used form of extracoporeal life support in 
children. Depending the underlying disease, it can be 
modied for venovenous blood ow, to provide su-
cient oxygenation of the blood in isolated respiratory 
failure, or for venoarterial support in the case of car-
diac and/or respiratory failure. Echocardiography 
plays an important role at every step of ECMO, starting 
with the diagnosis, and including documentation of 
cannula position, and guidance during surgical cannu-
lation and during troubleshooting. In contrast to adult 
patients, neck cannulation or central cannulation via 
median sternotomy are the preferred sites in children. 
Special circuits are available for the paediatric popula-
tion in order to keep priming volume low, guarantee 
optimal ow and oxygenation, and reduce complica-
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tion rates. Special management on the ICU is crucial to 
prevent or recognise complications. Interaction be-
tween the various disciplines involved is indispensa-
ble to identing the ideal timeframe for successful 
weaning. Involvement of the parents throughout all 
stages of therapy is important and may have a positive 
impact. 
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